It has been confirmed that SIRT2 can act as a histone lactylation eraser to inhibit proliferation and migration of neuroblastoma cells (53), and that SIRT3-dependent delactylation of cell cycle protein E2 can prevent the growth of HCC (54). The gene discussed is SIRT3; the disease is hepatocellular carcinoma.